Business
Media
Conferences
Publications
CME/CE
Resources
Subscribe

Christopher Lee, MD

Articles by Christopher Lee, MD

Genomic testing helps inform treatment intensity decisions in intermediate-risk prostate cancer

ByChristopher Lee, MD

October 2nd 2025

Latest Updated Articles

Genomic testing helps inform treatment intensity decisions in intermediate-risk prostate cancer
October 2nd 2025

Trending on Urology Times

Lymph Node Dissection Following Systemic Therapy in MIBC

European Commission approves perioperative EV/pembrolizumab for cisplatin-ineligible MIBC

Mina Fam, MD, highlights significance of tebipenem pivoxil approval for cUTI

NCCN recommends ctDNA-MRD testing to guide adjuvant treatment post-cystectomy

Unmet needs and emerging solutions in MRI-guided prostate cancer care